VCNX
Price:
$5.63
Market Cap:
$9.73M
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical devel...[Read more]
Industry
Biotechnology
IPO Date
2018-08-09
Stock Exchange
NASDAQ
Ticker
VCNX
According to Vaccinex, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.11%. This represents a change of 1.29% compared to the average of 80.08% of the last 4 quarters.
The mean historical ROE of Vaccinex, Inc. over the last ten years is 164.11%. The current 1.11% ROE has changed 577.41% with respect to the historical average. Over the past ten years (40 quarters), VCNX's ROE was at its highest in in the September 2018 quarter at 3.03%. The ROE was at its lowest in in the March 2021 quarter at -803.67%.
Average
164.11%
Median
129.17%
Minimum
-379.78%
Maximum
876.29%
Discovering the peaks and valleys of Vaccinex, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 151.19%
Maximum Annual ROE = 876.29%
Minimum Annual Increase = -384.20%
Minimum Annual ROE = -379.78%
Year | ROE | Change |
---|---|---|
2023 | 876.29% | -330.74% |
2022 | -379.78% | 21.17% |
2021 | -313.44% | -384.20% |
2020 | 110.29% | -9.62% |
2019 | 122.02% | -64.36% |
2018 | 342.40% | 151.19% |
2017 | 136.31% | -67.46% |
The current ROE of Vaccinex, Inc. (VCNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
61.02%
5-year avg
83.08%
10-year avg
164.11%
Vaccinex, Inc.’s ROE is greater than Protara Therapeutics, Inc. (-55.03%), greater than Monopar Therapeutics Inc. (-110.60%), greater than Miromatrix Medical Inc. (-119.21%), greater than Surrozen, Inc. (-178.66%), greater than First Wave BioPharma, Inc. (-28.76%), greater than Salarius Pharmaceuticals, Inc. (-148.64%), greater than SAB Biotherapeutics, Inc. (-94.04%), greater than GeoVax Labs, Inc. (-852.58%), less than ZIVO Bioscience, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (673.84%), greater than Erasca, Inc. (-24.51%), greater than Forte Biosciences, Inc. (-131.94%), greater than Applied Molecular Transport Inc. (-117.85%), greater than RenovoRx, Inc. (-218.56%), greater than Anebulo Pharmaceuticals, Inc. (-403.38%), greater than Eledon Pharmaceuticals, Inc. (-122.97%), greater than null (-124.74%),
Company | ROE | Market cap |
---|---|---|
-55.03% | $38.27M | |
-110.60% | $8.41M | |
-119.21% | $92.95M | |
-178.66% | $29.60M | |
-28.76% | $5.99M | |
-148.64% | $2.15M | |
-94.04% | $26.21M | |
-852.58% | $28.68M | |
0% | $37.03M | |
673.84% | $181.50M | |
-24.51% | $807.96M | |
-131.94% | $11.11M | |
-117.85% | $11.01M | |
-218.56% | $24.47M | |
-403.38% | $46.68M | |
-122.97% | $100.73M | |
-124.74% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccinex, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaccinex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vaccinex, Inc.'s ROE?
How is the ROE calculated for Vaccinex, Inc. (VCNX)?
What is the highest ROE for Vaccinex, Inc. (VCNX)?
What is the 3-year average ROE for Vaccinex, Inc. (VCNX)?
What is the 5-year average ROE for Vaccinex, Inc. (VCNX)?
How does the current ROE for Vaccinex, Inc. (VCNX) compare to its historical average?